Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes (Q57628743)

From Wikidata

Jump to navigation Jump to search

article by Mihai Gheorghiade et al published September 2012 in European Journal of Heart Failure

Language	Label	Description	Also known as
English	Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes	article by Mihai Gheorghiade et al published September 2012 in European Journal of Heart Failure

Statements

scholarly article

0 references

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes (English)

0 references

1 reference

based on heuristic

inferred from title

Acute decompensated heart failure

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

object named as

Aldo Maggioni

7

0 references

Mihai Gheorghiade

1

object named as

Mihai Gheorghiade

0 references

Gerasimos Filippatos

3

object named as

Gerasimos Filippatos

0 references

Alexandre Mebazaa

9

object named as

Alexandre Mebazaa

0 references

Stephen J Greene

2

object named as

Stephen J. Greene

0 references

Christina Nowack

8

object named as

Christina Nowack

0 references

6

object named as

Phillip D. Levy

0 references

author name string

Erland Erdmann

4

0 references

Roberto Ferrari

5

0 references

publication date

September 2012

0 references

European Journal of Heart Failure

0 references

14

0 references

9

0 references

1056-1066

0 references

Acute heart failure syndromes: current state and framework for future research

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Effects of tolvaptan on dyspnoea relief from the EVEREST trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

HFSA 2010 Comprehensive Heart Failure Practice Guideline

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Effect of nesiritide in patients with acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS093

21 January 2018

Identifiers

10.1093/EURJHF/HFS093

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57628743&oldid=2114330976"